Daginakatte GC - Search Results

1

Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.

Daginakatte GC, Gutmann DH. Daginakatte GC, et al. Hum Mol Genet. 2007 May 1;16(9):1098-112. doi: 10.1093/hmg/ddm059. Epub 2007 Mar 30. Hum Mol Genet. 2007. PMID: 17400655

2

Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.

Warrington NM, Woerner BM, Daginakatte GC, Dasgupta B, Perry A, Gutmann DH, Rubin JB. Warrington NM, et al. Among authors: daginakatte gc. Cancer Res. 2007 Sep 15;67(18):8588-95. doi: 10.1158/0008-5472.CAN-06-2220. Cancer Res. 2007. PMID: 17875698

3

Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.

Daginakatte GC, Gianino SM, Zhao NW, Parsadanian AS, Gutmann DH. Daginakatte GC, et al. Cancer Res. 2008 Dec 15;68(24):10358-66. doi: 10.1158/0008-5472.CAN-08-2506. Cancer Res. 2008. PMID: 19074905

4

Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic AMP or proinflammatory cytokines.

Daginakatte GC, Gadzinski A, Emnett RJ, Stark JL, Gonzales ER, Yan P, Lee JM, Cross AH, Gutmann DH. Daginakatte GC, et al. Exp Neurol. 2008 Mar;210(1):261-7. doi: 10.1016/j.expneurol.2007.10.016. Epub 2007 Nov 7. Exp Neurol. 2008. PMID: 18054918

5

Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases.

Murone M, Vaslin Chessex A, Attinger A, Ramachandra R, Shetty SJ, Daginakatte G, Sengupta S, Marappan S, Dhodheri S, Rigotti S, Bachhav Y, Brienza S, Traxler P, Lang M, Aguet M, Zoete V, Michielin O, Nicholas C, Johnson FM, Ramachandra M, McAllister A. Murone M, et al. Mol Cancer Ther. 2016 Oct;15(10):2334-2343. doi: 10.1158/1535-7163.MCT-15-0974. Epub 2016 Jul 20. Mol Cancer Ther. 2016. PMID: 27439479

6

Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies.

Gummadi VR, Boruah A, Ainan BR, Vare BR, Manda S, Gondle HP, Kumar SN, Mukherjee S, Gore ST, Krishnamurthy NR, Marappan S, Nayak SS, Nellore K, Balasubramanian WR, Bhumireddy A, Giri S, Gopinath S, Samiulla DS, Daginakatte G, Basavaraju A, Chelur S, Eswarappa R, Belliappa C, Subramanya HS, Booher RN, Ramachandra M, Samajdar S. Gummadi VR, et al. ACS Med Chem Lett. 2020 Oct 14;11(12):2374-2381. doi: 10.1021/acsmedchemlett.0c00255. eCollection 2020 Dec 10. ACS Med Chem Lett. 2020. PMID: 33335659 Free PMC article.

7

Mapping of the RNA-binding domain of the porcine reproductive and respiratory syndrome virus nucleocapsid protein.

Daginakatte GC, Kapil S. Daginakatte GC, et al. Adv Exp Med Biol. 2001;494:547-52. doi: 10.1007/978-1-4615-1325-4_80. Adv Exp Med Biol. 2001. PMID: 11774522 No abstract available.

8

Production, characterization, and uses of monoclonal antibodies against recombinant nucleoprotein of elk coronavirus.

Daginakatte GC, Chard-Bergstrom C, Andrews GA, Kapil S. Daginakatte GC, et al. Clin Diagn Lab Immunol. 1999 May;6(3):341-4. doi: 10.1128/CDLI.6.3.341-344.1999. Clin Diagn Lab Immunol. 1999. PMID: 10225833 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters